NKGen Biotech Stock (NASDAQ:NKGN)


FinancialsChart

Previous Close

$0.64

52W Range

$0.20 - $4.06

50D Avg

$0.38

200D Avg

$0.99

Market Cap

$22.84M

Avg Vol (3M)

$1.36M

Beta

0.52

Div Yield

-

NKGN Company Profile


Graf Acquisition Corp. IV does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. Graf Acquisition Corp. IV was incorporated in 2021 and is based in The Woodlands, Texas.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

63

IPO Date

Oct 02, 2023

Website

NKGN Performance


NKGN Financial Summary


Dec 23Dec 22Dec 21
Revenue-$77.00K$426.00K
Operating Income$-29.75M$-24.35M$-21.86M
Net Income$-82.95M$-26.75M$-23.27M
EBITDA$-28.54M$-22.79M$-20.70M
Basic EPS$-5.38$-0.82$-0.71
Diluted EPS$-5.38$-0.82$-0.71

Fiscal year ends in Dec 23 | Currency in USD